The U.S. Food and Drug Administration has cleared the ovarian cancer drug Lynparza to treat advanced pancreatic cancer, according to AstraZeneca and Merck, the companies that developed it.
Read more: https://www.10tv.com/article/fda-approves-drug-treating-pancreatic-cancer-2019-dec?source=Snapzu
No comments:
Post a Comment